Management of Hypotension In the Preterm: A multi centre, randomised, controlled trial of hypotension management in the extremely low gestational age newborn. - HIP Trial

BrepCo Biopharma Limited0 个研究点目标入组 830 人开始时间: 2014年4月24日最近更新: 2024年5月13日

试验速览

暂无简介。

•Gestational age from 23 weeks at birth to less than 28 completed weeks (i.e. up to and including 27 weeks and 6 days).
•Within 72 hours of birth.
•An indwelling arterial line, suitably calibrated and zeroed, to monitor blood pressure.
•A pre-trial cranial ultrasound scan free of grade III-IV IVH or cystic PVL.
•A mean blood pressure (BP) 1 mmHg or more below a mean BP value equivalent to the GA in completed weeks, which persists over a 15 minute period.
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 830
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Infant is considered non-viable by attending clinicians.
•Life-threatening congenital abnormalities including congenital heart disease and chromosomal abnormalities.
•Infants known to require surgical treatment.
•Hydrops Fetalis.

发起方